The customer reported that she was using a humalog insulin pen developed by lilly that was defective and caused her to task too much insulin.She reported a consequent hypoglycemic event in which she went into a coma and that she had a seizure while in the coma.The customer's daughter found her and called an ambulance.Customer was treated at a hospital with an iv.Customer does not know what was in the iv.N/a.This report reflects information received by fda in the form of a notification per 803.22 (b)(2).
|